XML 41 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders’ Equity (Details Narrative)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Mar. 26, 2021
$ / shares
shares
Feb. 28, 2021
shares
Jan. 31, 2021
USD ($)
$ / shares
shares
Nov. 19, 2020
shares
Jun. 23, 2020
Apr. 06, 2020
USD ($)
$ / shares
shares
Mar. 31, 2021
$ / shares
shares
Apr. 30, 2020
shares
Feb. 28, 2020
$ / shares
shares
Jan. 31, 2020
$ / shares
shares
Jun. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Mar. 31, 2020
shares
Jun. 30, 2021
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
May 24, 2021
shares
Subsidiary, Sale of Stock [Line Items]                                      
Common stock, shares authorized 24,000,000                       24,000,000     24,000,000   24,000,000 12,000,000
Common stock issued during period     2,190,000   1,711,783           2,500                
Share price per share | $ / shares     $ 4.32   $ 3.00           $ 8.70                
Proceeds from public offering | $         $ 4,532,445                            
Term of warrants     2 years   5 years                            
Warrants exercise price | $ / shares         $ 3.75                            
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised                               495,641    
Warrants to purchase shares of common stock     2,190,000                                
Warrants exercisable date     May 24, 2021                                
Preferred stock, shares authorized 10,000,000                       10,000,000 10,000,000   10,000,000 10,000,000 10,000,000  
Preferred stock, par value | $ / shares $ 0.001                       $ 0.001 $ 0.001   $ 0.001 $ 0.001 $ 0.001  
Preferred stock, shares issued 465                       465 333   465 333 715  
Preferred stock, shares outstanding 465                       465 333   465 333 715  
Unrecognized share based compensation cost | $ $ 0                       $ 0 $ 7,870   $ 0 $ 7,870    
Unrecognized deferred compensation expense to be recognized over remainder of year | $ 0                       0     $ 0      
Number of shares granted                               145,487   579,998  
Share based compensation | $                               $ 233,919 $ 424,989    
Options exercise price | $ / shares                               $ 3.90      
Stock options compensation cost | $ $ 987,899                       $ 987,899     $ 987,899      
Weighted average remaining recognition period                               1 year 8 months 12 days      
2013 Equity Incentive Plan [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common shares granted for the period                   11,517                  
2013 Stock Option Plan [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock shares reserved for issuance 890,000                       890,000     890,000      
2020 Stock Appreciation Rights Plan [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Unrecognized share based compensation cost | $ $ 155,361                       $ 155,361     $ 155,361      
Options exercise price | $ / shares                               $ 3.90      
Weighted average remaining recognition period                               1 year 11 months 23 days      
Stock appreciation rights granted description             the Company granted, pursuant to the Plan, (i) 60,094 SARs to its President and Chief Executive Officer, (ii) 12,019 SARs to its Vice President of Business Development, (iii) 24,038 SARs to its Chief Technology Officer, and (iv) 18,028 SARs to its Chief Financial Officer. The exercise price of each such SAR is $2.63, which was the closing price of the Company’s common stock on the date of grant. Such SARs expire on the fifth anniversary of the grant date and may be settled only in cash. Additionally, each such SAR will vest and become exercisable in three equal (as closely as possible) installments on each of the first, second and third anniversaries of the grant date, subject, in each case, to the applicable SAR holder being in the continuous employ of the Company on the applicable vesting date, and, in the event of a Change in Control (as defined in the Plan), will become immediately vested and exercisable as long as the applicable holder is in the Company’s employ immediately prior to the Change in Control, and will otherwise be on such other terms set forth in the form of Stock Appreciation Rights Agreement.                        
5 Employees [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Number of shares granted                               145,487      
Vesting period                               3 years      
4 Directors [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Number of shares granted                               145,487      
Vesting period                               3 years      
3 Consultants [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Number of shares granted                               145,487      
Vesting period                               3 years      
19 Employees [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Number of shares granted                                 335,183    
Vesting period                                 3 years    
4 Consultants [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Number of shares granted                                 335,183    
Vesting period                                 3 years    
Dawson James Securities, Inc [Member] | Placement Agent [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Warrants to purchase shares of common stock               41,237                      
CorProminence [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period   1,500                                  
Share price per share | $ / shares   $ 4.99             $ 4.99                    
April 2020 Offering [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period   21,591                                  
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised   191,204                                  
Placement Agent Warrants [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Warrants exercise price | $ / shares   $ 5.55625             $ 5.55625                    
Warrants to purchase shares of common stock   175,200             175,200                    
Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Percentage of warrant exercise price   1.25             1.25                    
Consulting Agreement [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Number of shares granted           13,500                          
Common Stock [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period                           493,027   3,901,783 493,027    
Preferred stock dividend, shares                         323,624   19,000 410,425    
Common Stock [Member] | Placement Agent Warrants [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Percentage of warrant exercise price   0.08             0.08                    
Common Stock [Member] | Placement Agent Warrants [Member] | Measurement Input, Share Price [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Percentage of warrant exercise price   0.080             0.080                    
Pre-funded Warrants [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Warrants exercise price | $ / shares               $ 3.64                      
Warrants to purchase shares of common stock               22,438                      
Stock Options [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Share based compensation | $                               $ 233,919 $ 417,119    
Series D Convertible Preferred Stock [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period                             408,318   1,603,984    
Conversion of stock, shares converted                             1,107   1,684    
Number of shares as in-kind payment, shares                             86,801        
Preferred stock dividend, shares                                 323,624    
Series D Convertible Preferred Stock [Member] | Common Stock [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Conversion of stock, shares converted   250                                  
Number of shares as in-kind payment, shares   19,000                                  
Series A Warrants [Member] | Pre-funded Warrants [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Warrants to purchase shares of common stock               515,465                      
Series D Preferred Stock [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period 62,832                                    
Preferred stock, shares outstanding 132                       132     132      
Conversion price per share | $ / shares $ 2.50                       $ 2.50     $ 2.50      
Series D Preferred Stock [Member] | Institutional Securities Purchase Agreement [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Share issued and sold during period, shares                       1,640              
Preferred stock, par value | $ / shares                       $ 1,000              
Dividends percentage                       9.00%              
Conversion price per share | $ / shares                       $ 2.50              
Conversion description                       In addition, a holder may at any time, alternatively, convert all, or any part, of its Series D Preferred Shares at an alternative conversion price, which equals the lower of the applicable conversion price then in effect, and the greater of (x) $1.80 and (y) 85% of the average volume weighted average price (“VWAP”) of the Common Stock for a five (5) trading day period prior to such conversion. Upon the occurrence of certain triggering events, described in the Certificate of Designations, including, but not limited to payment defaults, breaches of transaction documents, failure to maintain listing on the Nasdaq Capital Market, and other defaults set forth therein, the Series D Preferred Shares would become subject to redemption, at the option of a holder, at a 125% premium to the underlying value of the Series D Preferred Shares being redeemed.              
Series E Convertible Preferred Stock [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period 61,651                                    
Series E Convertible Preferred Stock [Member] | Other Securities Purchase Agreement [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Conversion of stock, shares converted 48,544                                    
Share issued and sold during period, shares 333                                    
Dividends percentage 9.00%                                    
Private Placement [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period   119,000   263,200                              
Private Placement [Member] | Purchase Agreement [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Term of warrants   2 years             2 years                    
Warrants exercise price | $ / shares   $ 4.32             $ 4.32                    
Warrants to purchase shares of common stock   2,190,000             2,190,000                    
Warrants exercisable date                 May 24, 2021                    
Public Offering [Member]                                      
Subsidiary, Sale of Stock [Line Items]                                      
Common stock issued during period   2,190,000                                  
Share price per share | $ / shares   $ 4.445             $ 4.445                    
Proceeds from public offering | $   $ 8,736,487           $ 1,230,000                      
Share issued and sold during period, shares               493,027